Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 5/10

vs
industry
vs
history
Cash to Debt 0.18
IMRS's Cash to Debt is ranked higher than
50% of the 287 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.15 vs. IMRS: 0.18 )
IMRS' s 10-Year Cash to Debt Range
Min: 0.18   Max: No Debt
Current: 0.18

Equity to Asset 0.25
IMRS's Equity to Asset is ranked lower than
51% of the 275 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.60 vs. IMRS: 0.25 )
IMRS' s 10-Year Equity to Asset Range
Min: 0.25   Max: 0.86
Current: 0.25

0.25
0.86
F-Score: 2
Z-Score: -1.62
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 1/10

vs
industry
vs
history
Operating margin (%) -130.84
IMRS's Operating margin (%) is ranked lower than
52% of the 286 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9.64 vs. IMRS: -130.84 )
IMRS' s 10-Year Operating margin (%) Range
Min: -180.07   Max: -1.01
Current: -130.84

-180.07
-1.01
Net-margin (%) -152.98
IMRS's Net-margin (%) is ranked lower than
52% of the 286 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.97 vs. IMRS: -152.98 )
IMRS' s 10-Year Net-margin (%) Range
Min: -184.84   Max: -2.02
Current: -152.98

-184.84
-2.02
ROE (%) -148.39
IMRS's ROE (%) is ranked lower than
53% of the 276 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 8.15 vs. IMRS: -148.39 )
IMRS' s 10-Year ROE (%) Range
Min: -103.84   Max: -2.31
Current: -148.39

-103.84
-2.31
ROA (%) -57.05
IMRS's ROA (%) is ranked lower than
51% of the 288 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.87 vs. IMRS: -57.05 )
IMRS' s 10-Year ROA (%) Range
Min: -52.53   Max: -1.6
Current: -57.05

-52.53
-1.6
ROC (Joel Greenblatt) (%) -421.33
IMRS's ROC (Joel Greenblatt) (%) is ranked lower than
53% of the 287 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 20.54 vs. IMRS: -421.33 )
IMRS' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -1063.97   Max: -6.28
Current: -421.33

-1063.97
-6.28
Revenue Growth (%) -22.20
IMRS's Revenue Growth (%) is ranked higher than
51% of the 261 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.50 vs. IMRS: -22.20 )
IMRS' s 10-Year Revenue Growth (%) Range
Min: -22.2   Max: 65.3
Current: -22.2

-22.2
65.3
EPS Growth (%) 163.40
IMRS's EPS Growth (%) is ranked higher than
99% of the 218 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.90 vs. IMRS: 163.40 )
IMRS' s 10-Year EPS Growth (%) Range
Min: -59.8   Max: 163.4
Current: 163.4

-59.8
163.4
» IMRS's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

IMRS Guru Trades in

IMRS Guru Trades in

IMRS Guru Trades in

Q3 2014

IMRS Guru Trades in Q3 2014

Jim Simons 36,500 sh (New)
» More
» Details

Insider Trades

Latest Guru Trades with IMRS

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)



No Guru Trades Found!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/B 0.90
IMRS's P/B is ranked higher than
96% of the 300 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.51 vs. IMRS: 0.90 )
IMRS' s 10-Year P/B Range
Min: 0.84   Max: 13.95
Current: 0.9

0.84
13.95
P/S 0.40
IMRS's P/S is ranked higher than
97% of the 300 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.92 vs. IMRS: 0.40 )
IMRS' s 10-Year P/S Range
Min: 0.42   Max: 6.51
Current: 0.4

0.42
6.51
EV-to-EBIT -0.77
IMRS's EV-to-EBIT is ranked lower than
55% of the 300 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 29.27 vs. IMRS: -0.77 )
IMRS' s 10-Year EV-to-EBIT Range
Min: -305.2   Max: -0.8
Current: -0.77

-305.2
-0.8

Valuation & Return

vs
industry
vs
history
Price/Tangible Book 0.88
IMRS's Price/Tangible Book is ranked higher than
97% of the 300 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.41 vs. IMRS: 0.88 )
IMRS' s 10-Year Price/Tangible Book Range
Min: 1.47   Max: 31.05
Current: 0.88

1.47
31.05
Price/Median PS Value 0.13
IMRS's Price/Median PS Value is ranked higher than
99% of the 300 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.20 vs. IMRS: 0.13 )
IMRS' s 10-Year Price/Median PS Value Range
Min: 0.32   Max: 1.9
Current: 0.13

0.32
1.9
Earnings Yield (Greenblatt) -129.90
IMRS's Earnings Yield (Greenblatt) is ranked lower than
57% of the 284 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.00 vs. IMRS: -129.90 )
IMRS' s 10-Year Earnings Yield (Greenblatt) Range
Min: 0   Max: 0
Current: -129.9

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies
Compare: » details
Traded in other countries:IM.Canada, 9IM.Germany
IMRIS Inc was incorporated on May 18,2005 under the Canada Business Corporations Act. The Company designs, manufactures and markets the VISIUS Surgical TheatreTM, a multifunctional surgical environment that provides intraoperative vision to clinicians to assist in decision-making and enhance precision in treatment. It also provides ancillary products and services and extended maintenance services. Designed to meet each hospital's specific clinical application needs, the VISIUS Surgical Theatre can incorporate MR imaging, CT imaging and x-ray angiography in a number of configurations to provide intraoperative images of diagnostic quality without introducing additional patient transport risk and delivering real-time information to clinicians while preserving optimal surgical access and techniques. The Company sells the VISIUS Surgical Theatres to hospitals that deliver clinical services to patients in the neurosurgical, cerebrovascular and cardiovascular markets.
» More Articles for IMRS

Headlines

Articles On GuruFocus.com
No related article found.

More From Other Websites
Nasdaq stocks posting largest volume increases Nov 26 2014
IMRIS CEO Jay D. Miller to present at the Canaccord Genuity Medical Technologies & Diagnostics Forum Nov 17 2014
IMRIS neurosurgical suite opens at Boca Raton Regional Hospital Oct 29 2014
IMRIS neurosurgical suite opens at Boca Raton Regional Hospital Oct 29 2014
IMRIS Reports Third-Quarter 2014 Financial Results Oct 28 2014
IMRIS Reports Third-Quarter 2014 Financial Results Oct 28 2014
IMRIS to Hold Third Quarter 2014 Financial Results Conference Call Oct 22 2014
IMRIS to Hold Third Quarter 2014 Financial Results Conference Call Oct 22 2014
3 Stocks Advancing The Health Services Industry Oct 17 2014
IMRIS intraoperative imaging solutions provide optimized visualization platform for emerging... Oct 09 2014
IMRIS intraoperative imaging solutions provide optimized visualization platform for emerging... Oct 09 2014
IMRIS Horseshoe headrest named Life Sciences Alley New Technology Showcase winner Sep 30 2014
IMRIS Horseshoe headrest named Life Sciences Alley New Technology Showcase winner Sep 30 2014
Unique IMRIS hybrid OR enables highly complex deformity correction at Dartmouth-Hitchcock Medical... Sep 25 2014
Unique IMRIS hybrid OR enables highly complex deformity correction at Dartmouth-Hitchcock Medical... Sep 25 2014
IMRIS Announces Waiver and Amendment Agreement and Repricing of Warrants Sep 24 2014
IMRIS Announces Waiver and Amendment Agreement and Repricing of Warrants Sep 24 2014
IMRIS CEO Jay D. Miller to present at the 5th Annual Craig-Hallum Alpha Select Conference Sep 15 2014
IMRIS CEO Jay D. Miller to present at the 5th Annual Craig-Hallum Alpha Select Conference Sep 15 2014
IMRIS neurosurgical HFD rocker arm receives FDA clearance Sep 11 2014

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK